Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 29:9:1108.
doi: 10.3389/fmicb.2018.01108. eCollection 2018.

Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus

Affiliations
Review

Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus

Nilce M Martinez-Rossi et al. Front Microbiol. .

Abstract

Dermatophytes comprise pathogenic fungi that have a high affinity for the keratinized structures present in nails, skin, and hair, causing superficial infections known as dermatophytosis. A reasonable number of antifungal drugs currently exist on the pharmaceutical market to control mycoses; however, their cellular targets are restricted, and fungi may exhibit tolerance or resistance to these agents. For example, the stress caused by antifungal and cytotoxic drugs in sub-inhibitory concentrations promotes compensatory stress responses, with the over-expression of genes involved in cellular detoxification, drug efflux, and signaling pathways being among the various mechanisms that may contribute to drug tolerance. In addition, the ATP-binding cassette transporters in dermatophytes that are responsible for cellular efflux can act synergistically, allowing one to compensate for the absence of the other, revealing the complexity of drug tolerance phenomena. Moreover, mutations in genes coding for target enzymes could lead to substitutions in amino acids involved in the binding of antifungal agents, hindering their performance and leading to treatment failure. The relevance of each one of these mechanisms of resistance to fungal survival is hard to define, mainly because they can act simultaneously in the cell. However, an understanding of the molecular mechanisms involved in the resistance/tolerance processes, the identification of new antifungal targets, as well as the prospective of new antifungal compounds among natural or synthetic products, are expected to bring advances and new insights that facilitate the improvement or development of novel strategies for antifungal therapy.

Keywords: Hsp; dermatophyte; drug resistance; drug target; kinase; natural compounds; stress response.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Alignment of amino acid sequences of squalene epoxidase (SE) of T. mentagrophytes, T. rubrum, A. fumigatus, and S. cerevisiae. The six residues with point mutations associated with terbinafine resistance are indicated by red contour. The boxes represent point mutations in SE from T. mentagrophytes and T. rubrum (blue), A. fumigatus (red), and S. cerevisiae (green). Asterisks are related to identical residues in the four species, whereas two dots or one dot represent a higher and lower degree of conservation, respectively.

Similar articles

Cited by

References

    1. Agarwal A. K., Xu T., Jacob M. R., Feng Q., Lorenz M. C., Walker L. A., et al. (2008). Role of heme in the antifungal activity of the azaoxoaporphine alkaloid sampangine. Eukaryot. Cell 7 387–400. 10.1128/EC.00323-07 - DOI - PMC - PubMed
    1. Akerfelt M., Morimoto R. I., Sistonen L. (2010). Heat shock factors: integrators of cell stress, development and lifespan. Nat. Rev. Mol. Cell Biol. 11 545–555. 10.1038/nrm2938 - DOI - PMC - PubMed
    1. Arendrup M. C., Jensen R. H., Cuenca-Estrella M. (2016). In vitro activity of ASP2397 against Aspergillus isolates with or without acquired azole resistance mechanisms. Antimicrob. Agents Chemother. 60 532–536. 10.1128/AAC.02336-15 - DOI - PMC - PubMed
    1. Arif T., Bhosale J. D., Kumar N., Mandal T. K., Bendre R. S., Lavekar G. S., et al. (2009). Natural products–antifungal agents derived from plants. J. Asian Nat. Prod. Res. 11 621–638. 10.1080/10286020902942350 - DOI - PubMed
    1. Arrese J. E., Pierard-Franchimont C., Pierard G. E. (2001). A plea to bridge the gap between antifungals and the management of onychomycosis. Am. J. Clin. Dermatol. 2 281–284. 10.2165/00128071-200102050-00002 - DOI - PubMed

LinkOut - more resources